NCT01749033

Brief Summary

A laryngeal mask airway ("LMA") is an airway device that is commonly used and placed under general anesthesia to facilitate ventilation of the patient's lungs while anesthetized. It is similar to an "endotracheal tube" (a breathing tube) but is less invasive. It is also placed as a backup when the Anesthesiologist is unable to pass a breathing tube and the patient is not adequately ventilating. Unfortunately, an LMA may lead to complications similar to those of breathing tube placement, such as sore throat and hoarse voice. Previous studies have examined several variables that may affect how often complications occur; these variables include giving anti-inflammatory medications and inflating the LMA to different pressures (the "working" end of the LMA, which rests in the patient's throat, has a cuff that is inflated to provide a seal). We are studying the effect of the PLACEMENT TECHNIQUE on postoperative sore throat, hoarse voice, and difficulty swallowing. We will be using 3 placement techniques - the traditional placement technique, a slightly different traditional placement technique, and a new technique, abbreviated the "ELLIA" method. The hypothesis of this study is that a new LMA insertion technique will have no difference in postoperative pharyngolaryngeal morbidity including sore throat, dysphagia and dysphonia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

December 11, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 13, 2012

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
4 years until next milestone

Results Posted

Study results publicly available

December 17, 2019

Completed
Last Updated

December 17, 2019

Status Verified

December 1, 2019

Enrollment Period

4.1 years

First QC Date

December 11, 2012

Results QC Date

April 16, 2017

Last Update Submit

December 15, 2019

Conditions

Keywords

IntubationAirwayLaryngeal Mask Airway

Outcome Measures

Primary Outcomes (4)

  • Number of Subjects Who Present With Postoperative Sore Throat

    The primary outcomes for this study will be postoperative pharyngolaryngeal complications of sore throat as reported by the participant.

    24 hours

  • The Primary Outcomes for This Study Will be Postoperative Pharyngolaryngeal Complications Including Dysphonia

    The primary outcomes for this study will be postoperative pharyngolaryngeal complications including dysphonia. Difficulty in speaking as assessed by the study team and reported by the participant 24 hours after LMA airway placement.

    24 hours

  • The Primary Outcomes for This Study Will be Postoperative Dysphagia.

    The primary outcomes for this study will be postoperative pharyngolaryngeal complication of dysphagia 24 hours after airway placement. This is assessed by a study team member during the 24 hour follow up or reported by the participant.

    24 hours

  • The Primary Outcomes for This Study Will be Postoperative Pharyngolaryngeal Complications Including Dysphagia, Sore Throat and Dysphonia.

    The primary outcomes for this study will be postoperative pharyngolaryngeal complications including dysphagia, sore throat and dysphonia 24 hours after airway placement.

    24 hours

Secondary Outcomes (2)

  • Severity of Sore Throat

    24 hours

  • Blood on LMA After Removal

    Immediately after LMA removal

Study Arms (3)

Group 1 classic

ACTIVE COMPARATOR

Group 1 Using the classic inserting technique and completely deflated LMA (Laryngeal Mask Airway)recommended in the LMA manual.

Other: Group 1 Classic

Group 2 pre inflated

ACTIVE COMPARATOR

Group 2 (pre-inflated): Using the recommended inserting technique with the pre-inflated volume that exists in a LMA (Laryngeal Mask Airway) from the manufacturer

Other: Group 2 pre-inflated

Group 3 ELL-PIC technique

ACTIVE COMPARATOR

Group 3 (ELL-PIC): Using the ELL-PIC technique.

Other: Group 3 ELL-PIC

Interventions

Active Comparator: Group 1 classic Group 1 Using the classic inserting technique and completely deflated LMA recommended in the LMA manual.

Group 1 classic

Group 2 (pre-inflated): Using the recommended inserting technique with the pre-inflated volume that exists in a LMA (Laryngeal Mask Airway) from the manufacturer.

Group 2 pre inflated

Group 3 (ELL-PIC): Using the ELL-PIC technique

Group 3 ELL-PIC technique

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA (American Society of Anesthesiologists patient fitness category) I, II, III
  • Age 18-90
  • General anesthetic for where LMA (Laryngeal Mask Airway) placement is not contraindicated will be included

You may not qualify if:

  • Small mouth opening
  • Preoperative sore throat/dysphagia/dysphonia
  • Patients at increased risk for aspiration
  • Morbid obesity BMI \> 40
  • Untreated chronic GERD
  • Pregnancy
  • Suspected supraglottic abnormalities
  • N2O use
  • Need for oral-pharyngeal suctioning
  • Undergoing oral and nasal surgery
  • Intubation or any oral instrumental manipulations other than
  • LMA placements intraoperatively or postoperatively

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

Location

Related Publications (1)

  • Hu LQ, Leavitt OS, Malwitz C, Kim H, Doty RA Jr, McCarthy RJ. Comparison of laryngeal mask airway insertion methods, including the external larynx lift with pre-inflated cuff, on postoperative pharyngolaryngeal complications: A randomised clinical trial. Eur J Anaesthesiol. 2017 Jul;34(7):448-455. doi: 10.1097/EJA.0000000000000650.

Limitations and Caveats

We did not limit the intracuff pressure of the device, but rather used the manufactures recommended volume in the cuff. . There are no current standard of care guidelines for the ideal intracuff pressures within the oropharngolaryngeal mask airway.

Results Point of Contact

Title
Ling Hu M.D.
Organization
Northwerstern University

Study Officials

  • David Walega, MD

    Northwestern University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 11, 2012

First Posted

December 13, 2012

Study Start

November 1, 2011

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

December 17, 2019

Results First Posted

December 17, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations